Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Analyst picks & changes

InterMune Pharmaceuticals Inc.

(ITMN), Burlingame, Calif.

Business: Musculoskeletal, Infectious diseases, Pulmonary

Chase H&Q analyst Meg Malloy began coverage

Read the full 181 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE